Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
  • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
  • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D233/68—Halogen atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/4164—1,3-Diazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/12—Antihypertensives
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
  • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
  • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D233/70—One oxygen atom
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
  • Y02P20/00—Technologies relating to chemical industry
  • Y02P20/50—Improvements relating to the production of bulk chemicals
  • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Engineering & Computer Science (AREA)
• Heart & Thoracic Surgery (AREA)
• Cardiology (AREA)
• Pain & Pain Management (AREA)
• Rheumatology (AREA)
• Epidemiology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Plural Heterocyclic Compounds (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Catalysts (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=43383440

Family Applications (1)

Country Status (19)

Families Citing this family (4)

Family Cites Families (9)

• 2010
  • 2010-09-21 TW TW099132085A patent/TWI545114B/zh not_active IP Right Cessation
  • 2010-09-28 WO PCT/US2010/050481 patent/WO2011041284A1/en active Application Filing
  • 2010-09-28 NZ NZ598278A patent/NZ598278A/en not_active IP Right Cessation
  • 2010-09-28 EP EP10763266.3A patent/EP2483246B1/en not_active Not-in-force
  • 2010-09-28 AU AU2010300788A patent/AU2010300788B2/en not_active Ceased
  • 2010-09-28 MY MYPI2012000616A patent/MY160382A/en unknown
  • 2010-09-28 JP JP2012531107A patent/JP5787893B2/ja not_active Expired - Fee Related
  • 2010-09-28 CA CA2771160A patent/CA2771160A1/en not_active Abandoned
  • 2010-09-28 PH PH1/2012/500617A patent/PH12012500617A1/en unknown
  • 2010-09-28 BR BR112012007145A patent/BR112012007145A8/pt not_active IP Right Cessation
  • 2010-09-28 CN CN201610182336.3A patent/CN105837511A/zh active Pending
  • 2010-09-28 IN IN2000DEN2012 patent/IN2012DN02000A/en unknown
  • 2010-09-28 KR KR1020127010980A patent/KR101750977B1/ko not_active Expired - Fee Related
  • 2010-09-28 MX MX2012003616A patent/MX2012003616A/es active IP Right Grant
  • 2010-09-28 RU RU2012117812/04A patent/RU2552350C2/ru not_active IP Right Cessation
  • 2010-09-28 ES ES10763266.3T patent/ES2656820T3/es active Active
  • 2010-09-28 CN CN2010800399736A patent/CN102482229A/zh active Pending
  • 2010-09-28 US US12/891,964 patent/US8188294B2/en not_active Expired - Fee Related
• 2012
  • 2012-02-09 IL IL218003A patent/IL218003A/en not_active IP Right Cessation
  • 2012-03-27 ZA ZA2012/02218A patent/ZA201202218B/en unknown
  • 2012-04-25 US US13/455,339 patent/US8541597B2/en active Active
• 2013
  • 2013-08-22 US US13/973,171 patent/US8889882B2/en not_active Expired - Fee Related
• 2014
  • 2014-10-16 US US14/515,732 patent/US9221763B2/en not_active Expired - Fee Related
  • 2014-11-27 JP JP2014239570A patent/JP2015042683A/ja active Pending
  • 2014-11-27 JP JP2014239571A patent/JP2015044856A/ja active Pending

Also Published As

Similar Documents